Adaptive Biotechnologies (ADPT) Earnings Date, Estimates & Call Transcripts → Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (From InvestorPlace) (Ad) Free ADPT Stock Alerts $3.82 +0.32 (+9.14%) (As of 03:21 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 7EstimatedActual EPS (May. 7) -$0.33 Beat By $0.02 Consensus EPS (May. 7) -$0.35 Read Call TranscriptListen to Call Get Adaptive Biotechnologies Earnings AlertsEnter your email address below to receive the latest news and earnings results for ADPT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueADPT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ADPT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceYour Portfolio’s Shield Against Inflation: Gold’s Surge and AI BreakthroughsWhile gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation.Click to watch this device in action Adaptive Biotechnologies Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241($0.32)($0.32)($0.32) Q2 20241($0.33)($0.33)($0.33) Q3 20241($0.32)($0.32)($0.32) Q4 20241($0.31)($0.31)($0.31) FY 20244($1.28)($1.28)($1.28) Q1 20251($0.34)($0.34)($0.34) Q2 20251($0.33)($0.33)($0.33) Q3 20251($0.32)($0.32)($0.32) Q4 20251($0.30)($0.30)($0.30) FY 20254($1.29)($1.29) ($1.29)ADPT Earnings Date and InformationAdaptive Biotechnologies last posted its quarterly earnings results on May 7th, 2024. The reported ($0.33) earnings per share for the quarter, beating the consensus estimate of ($0.35) by $0.02. The business earned $41.87 million during the quarter, compared to the consensus estimate of $38.78 million. Its revenue for the quarter was up 11.2% compared to the same quarter last year. Adaptive Biotechnologies has generated ($1.49) earnings per share over the last year (($1.49) diluted earnings per share). Earnings for Adaptive Biotechnologies are expected to grow in the coming year, from ($1.30) to ($1.09) per share. Adaptive Biotechnologies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off prior year's report dates.Read More Adaptive Biotechnologies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/7/2024Estimated)------- 5/7/2024Q1 2024($0.35)($0.33)+$0.02($0.33)$38.78 million$41.87 million 2/14/2024Q4 2023($0.32)($0.30)+$0.02($0.12)$50.15 million$45.78 million11/9/2023Q3 2023($0.32)($0.35)($0.03)($0.35)$43.26 million$37.92 million8/2/2023Q2 2023($0.33)($0.33)-($0.33)$44.87 million$48.93 million 5/3/2023Q1 2023($0.34)($0.40)($0.06)($0.40)$36.81 million$37.65 million 2/14/2023Q4 2022($0.37)($0.28)+$0.09($0.28)$55.25 million$55.20 million Get the Latest News and Ratings for ADPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adaptive Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. 11/3/2022Q3 2022($0.37)($0.32)+$0.05($0.32)$48.41 million$47.80 million 8/3/2022Q2 2022($0.40)($0.37)+$0.03($0.37)$43.30 million$43.66 million 5/4/2022Q1 2022($0.45)($0.44)+$0.01($0.44)$37.71 million$38.62 million 2/15/2022Q4 2021($0.43)($0.43)-($0.43)$36.08 million$37.93 million 11/2/2021Q3 2021($0.42)($0.40)+$0.02($0.40)$37.60 million$39.47 million 8/3/2021Q2 2021($0.43)($0.35)+$0.08($0.35)$31.12 million$38.50 million Adaptive Biotechnologies Earnings - Frequently Asked Questions When is Adaptive Biotechnologies's earnings date? Adaptive Biotechnologies has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates. Learn more on ADPT's earnings history. Did Adaptive Biotechnologies beat their earnings estimates last quarter? In the previous quarter, Adaptive Biotechnologies (NASDAQ:ADPT) reported ($0.33) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.35) by $0.02. Learn more on analysts' earnings estimate vs. ADPT's actual earnings. How can I listen to Adaptive Biotechnologies's earnings conference call? The conference call for Adaptive Biotechnologies's latest earnings report can be listened to online. Listen to Conference Call How can I read Adaptive Biotechnologies's conference call transcript? The conference call transcript for Adaptive Biotechnologies's latest earnings report can be read online. Read Transcript How much revenue does Adaptive Biotechnologies generate each year? Adaptive Biotechnologies (NASDAQ:ADPT) has a recorded annual revenue of $170.28 million. How much profit does Adaptive Biotechnologies generate each year? Adaptive Biotechnologies (NASDAQ:ADPT) has a recorded net income of -$225.25 million. ADPT has generated -$1.49 earnings per share over the last four quarters. What is Adaptive Biotechnologies's EPS forecast for next year? Adaptive Biotechnologies's earnings are expected to grow from ($1.30) per share to ($1.09) per share in the next year. More Earnings Resources from MarketBeat Related Companies: iTeos Therapeutics Earnings Replimune Group Earnings TScan Therapeutics Earnings Aura Biosciences Earnings Jasper Therapeutics Earnings Tenaya Therapeutics Earnings Tourmaline Bio Earnings Lexeo Therapeutics Earnings Ocugen Earnings Solid Biosciences Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:ADPT) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorObama’s Forever Term [exposed]Porter & CompanyUrgent Nvidia WarningAltimetryThis 1 Biotech Stock has been shocking the marketsHuge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.